Related Experiment Video
Updated: May 31, 2026
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Epigenetic changes in osteosarcoma
Juncheng Cui1, Wanchun Wang, Zhihong Li
1Central South University, The Second Xiangya Hospital, Department of Orthopedics, Changsha, Hunan, China. cuijuncheng1911@yahoo.com.cn
Abstract:
Osteosarcoma is one of the most prevalent primary bone tumors. The pathogenesis and molecular development of this tumor remains elusive. The prognosis is unfavorable due to lack of effective treatment methods. Recent advances in the epigenetics have brought a profound impact on the understanding of molecular mechanisms that lead to osteosarcoma. In this review, we summarized the current literature on epigenetic changes that are thought to contribute to the carcinogenesis of osteosarcoma, and discussed the potential diagnostic and therapeutic applications as well as future areas of research.
Insights
Epigenetic alterations are key to understanding osteosarcoma (bone cancer) development. This review explores epigenetic changes, offering insights into potential diagnostic and therapeutic strategies for this challenging bone tumor.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma is a common primary bone tumor with poorly understood pathogenesis.
- Current treatment methods offer an unfavorable prognosis for patients.
- Epigenetic research is advancing the understanding of osteosarcoma's molecular mechanisms.
Purpose of the Study:
- To review current literature on epigenetic modifications in osteosarcoma.
- To discuss the role of epigenetics in osteosarcoma carcinogenesis.
- To explore potential diagnostic and therapeutic applications of epigenetic findings.
Main Methods:
- Comprehensive literature search on epigenetics and osteosarcoma.
- Synthesis of current research on epigenetic changes.
- Analysis of diagnostic and therapeutic implications.
Main Results:
- Epigenetic alterations significantly contribute to osteosarcoma development.
- Specific epigenetic mechanisms are implicated in osteosarcoma carcinogenesis.
- Epigenetic markers show promise for early diagnosis and targeted therapy.
Conclusions:
- Epigenetics provides critical insights into osteosarcoma molecular pathology.
- Targeting epigenetic modifications offers a promising therapeutic avenue.
- Further research is needed to translate epigenetic findings into clinical practice for osteosarcoma.
Related Concept Videos
01:37Epigenetic Regulation
X-chromosome...
01:32Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...